PhotoPharmics

company

About

PhotoPharmics is a clinical-stage medical device company developing next-generation treatments for treating neurodegenerative disorders.

  • 1 - 10

Details

Last Funding Type
Debt Financing
Last Funding Money Raised
$2.06M
Industries
Biotechnology,Health Care,Life Science,Medical,Medical Device,Pharmaceutical
Founded date
Jan 1, 2011
Number Of Employee
1 - 10
Operating Status
Active

PhotoPharmics is a clinical-stage medical device company developing next-generation treatments for treating neurodegenerative disorders through the eyes. We have 30+ years of research and experience in specialized phototherapy. We previously developed specialized solutions now widely used to regulate circadian rhythms for seasonal affective disorder, sleep disorders, anxiety, and depression (acquired by Philips-Respironics in 2007).

We are currently extending our research into several other neurodegenerative diseases. We aim to make a clinically meaningful difference in patients’ lives by delivering safe and effective treatments.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$4.14M
PhotoPharmics has raised a total of $4.14M in funding over 2 rounds. Their latest funding was raised on Jul 16, 2015 from a Debt Financing round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 16, 2015 Debt Financing $2.06M 1 Detail
Dec 27, 2012 Seed $2.08M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
PhotoPharmics is funded by 1 investors. PC Squared, LLC are the most recent investors.
Investor Name Lead Investor Funding Round
PC Squared, LLC Debt Financing